Medicine Description jurnista 32mg
Jurnista 32 mg tablets is a medication manufactured by Janssen Cilag that contains hydromorphone hydrochloride as its active ingredient. Hydromorphone hydrochloride is an opioid analgesic that works by binding to specific receptors in the brain and spinal cord, effectively reducing the perception of pain and altering the emotional response to discomfort.
Indications and Uses of Jurnista 32 mg tablets
- Management of moderate to severe pain.
- Pain relief in patients with cancer.
- Post-operative pain management.
- Chronic pain conditions requiring continuous opioid therapy.
How to Use Jurnista 32 mg tablets
- Swallow the tablet whole with water.
- Take with or without food as directed by the doctor or pharmacist.
- Do not crush or chew the tablet.
Contraindications of Jurnista 32 mg tablets
- Severe respiratory depression.
- Acute or severe asthma.
- Hypersensitivity to hydromorphone or any component of the product.
- Severe hepatic or renal impairment.
Drug Interactions
- Caution with other central nervous system depressants.
- May interact with monoamine oxidase inhibitors.
- Avoid use with medications that can affect liver enzymes.
Side Effects of Jurnista 32 mg tablets
- Drowsiness or sedation.
- Constipation.
- Nausea and vomiting.
- Dry mouth.
- Sweating.
- Potential for dependence and withdrawal symptoms.
Storage and Handling
Store at room temperature, away from moisture and direct sunlight. Keep out of reach of children and dispose of properly when no longer needed.
Warnings and Precautions
Use caution when driving as this medication may cause drowsiness. Pregnant and breastfeeding women should consult their healthcare provider before use. Use with caution in elderly patients and those with a history of substance abuse. Seek immediate medical attention if you experience difficulty breathing or severe dizziness.